You've just started tirzepatide: what to expect in the first weeks

Why do you feel different straight away, even at the lowest dose?

The 2.5mg pen activates two gut-hormone receptors simultaneously, GIP and GLP-1. Gastric emptying slows down, which is partly why food feels more satisfying sooner and partly why some people feel queasy. These effects can show up within the first 48 hours of your first injection, well before any meaningful weight change.

The good news is that this early discomfort is well-documented and, for most people, temporary. Clinical trial participants reported GI symptoms most frequently in the days following a new dose, with effects typically settling as the weeks progressed. The 2.5mg level exists precisely because starting lower means fewer people stop early due to side effects. Think of it less as treatment and more as acclimatisation.

A practical note that helps: keep your pen in the fridge door where you'll see it on injection day, and plan your meal timing loosely around the fact that your appetite may behave unpredictably for the first week or two. Small, lower-fat meals and staying well hydrated tend to reduce nausea noticeably. Your Patient Information Leaflet covers this in detail, it's worth actually reading it, not just filing it away.

If you have questions about how your first pen is going, our aftercare team is available seven days a week.

Which side effects are common and which ones need urgent attention?

Nausea is the most frequently reported early effect, followed by loose stools, constipation, indigestion, burping and fatigue. Injection-site redness or mild itching is also normal. None of these require stopping treatment, they're expected, especially in weeks one to four, and they tend to settle as your body adjusts to each dose level.

There are, however, symptoms that warrant prompt medical attention. Severe, persistent abdominal pain that radiates to the back (with or without vomiting) should be assessed urgently, as this pattern can indicate acute pancreatitis. The MHRA highlighted this in a Drug Safety Update in January 2026, confirming it as an infrequent but potentially serious effect of GLP-1 medicines. Other reasons to contact a doctor or call 111 include signs of a significant allergic reaction, symptoms of gallbladder problems (severe upper-right abdominal pain), or dehydration from persistent vomiting or diarrhoea.

You can report any suspected side effect directly through the MHRA's Yellow Card scheme, this applies whether the effect feels serious or just unusual. Patient reports actively contribute to the ongoing safety monitoring that keeps these medicines on the Black Triangle watch list for a reason.

What about dose increases, when does that happen?

Tirzepatide is licensed in UK strengths from 2.5mg up to 15mg. The standard approach is to step up roughly every four weeks, but that schedule is guided by your prescriber based on how you're tolerating each level, not by a fixed calendar. Moving up too quickly tends to intensify GI side effects without meaningfully improving outcomes sooner.

At nume, a clinician reviews your case before every repeat order. That review is done by a GPhC-registered Independent Prescriber reading your answers, not by an automated system making a decision on your behalf. If you're moving to a higher dose, evidence of your current weight is part of that assessment. You can read more about how tirzepatide treatment works at each stage or look at what the clinical evidence shows at the licensed dose range.

If you were transferred from another provider, your evidence of existing treatment informs where your titration continues. Skipping steps isn't something a responsible prescriber does; the schedule exists for clinical reasons.

Is there anything specific to sort out before your next injection?

A few practical checks matter in the early weeks. Women using the combined oral contraceptive pill need to use an additional contraceptive method for the first four weeks on tirzepatide and for four weeks after any dose increase, slowed gastric emptying can reduce pill absorption. This is specific to tirzepatide; NHS England's guidance on weight-management injections covers this alongside advice about HRT and surgery.

If you have any surgical procedure coming up, tell your anaesthetist and surgical team that you're taking tirzepatide. Slowed gastric emptying is relevant to anaesthetic risk.

For the wider picture on how private tirzepatide treatment fits together (including what's included in a single transparent price) the Mounjaro price comparison page explains what to look for when assessing any provider's costs. If you're ready to begin, our guide to starting tirzepatide walks you through what to expect before your first dose, and you can also find out what's included in our Mounjaro starter kit or review the full contents of the Mounjaro starter pack before ordering. And if you're still working out whether tirzepatide is the right option for your situation, our weight-loss treatment overview covers the licensed alternatives.

If anything about your first weeks on treatment is prompting questions, speaking to our prescribers is the right next step, they review patients seven days a week.